• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
NBSE

NBSE

NeuBase Therapeutics, Inc.

NASDAQHealthcareBiotechnologyUS

USD0.38

-0.01 (-1.56%)

Company Profile

CEO

Todd P. Branning

IPO Date

2004-05-28

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$0.38

Prev. Close

$0.38

Day Low

$0.36

Day High

$0.39

52W Low

$0.36

52W High

$4.44

Market Cap

$0.00B

Volume

0.09M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
Analyst Consensus
Buy

Strong Buy

0

Buy

3

Hold

3

Sell

0

Strong Sell

0

Analyst Grades
DateFirmPreviousNew GradeAction
21 Oct 2022OppenheimerOutperformPerformdowngrade
18 Oct 2022RBC CapitalOutperformSector Performdowngrade
17 Oct 2022Chardan CapitalBuyNeutraldowngrade
12 Aug 2022
Chardan Capital
Buy
Buy
maintain
31 May 2022HC Wainwright & Co.BuyBuymaintain
13 May 2022Chardan CapitalBuyBuymaintain
1 Jun 2021HC Wainwright & Co.BuyBuymaintain
12 Feb 2021HC Wainwright & Co.BuyBuymaintain
16 Jun 2020RBC CapitalOutperformOutperformmaintain
1 Apr 2020Chardan CapitalBuyBuymaintain